A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients with Noncardioembolic Cerebral Infarction
Authors:
- Yasuo FukuuchiYFYasuo Fukuuchi
- Hideo TohgiHTHideo Tohgi
- Toshio OkuderaTOToshio Okudera
- Yasuo IkedaYIYasuo Ikeda
- Yoshitaka MiyanagaYMYoshitaka Miyanaga
- Shinichiro UchiyamaSUShinichiro Uchiyama
- Masanori HiranoMHMasanori Hirano
- Yukito ShinoharaYSYukito Shinohara
- Masayasu MatsumotoMMMasayasu Matsumoto
- Takenori YamaguchiTYTakenori Yamaguchi
- 22 November 2007
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 25 (1-2) , 40-49
Abstract
Background: Patients treated with ticlopidine require careful hematologic monitoring. Clopidogrel may have greater tolerability. However, no direct comparison of these two drugs has been reported and evidence of improved safety with clopidogrel is not yet established in the Japanese population. A comparison of both agents was therefore conducted in Japanese stroke patients. Methods: Patients with noncardioembolic cerebral infarction were randomized to clopidogrel 75 mg or ticlopidine 200 mg once daily for 52 weeks. The primary endpoint was safety; the major secondary endpoint was the incidence of vascular events.Results: Clopidogrel was associated with significantly fewer safety events than ticlopidine (7.0 versus 15.1%; p < 0.001) and no significant difference in efficacy between the two treatments was seen [hazard ratio 0.977 (95% confidence interval: 0.488–1.957)].Conclusions: In Japanese stroke patients, clopidogrel 75 mg is better tolerated than ticlopidine 200 mg once daily.Keywords
This publication has 16 references indexed in Scilit:
- Prevalence, Awareness and Treatment of Cardiovascular Risk Factors in Patients at High Risk of Atherothrombosis in Japan Results From Domestic Baseline Data of the REduction of Atherotherombosis for Continued Health (REACH) RegistryCirculation Journal, 2007
- New Modalities and Aspects of Antiplatelet Therapy for Stroke PreventionCerebrovascular Diseases, 2006
- Antiplatelet Therapy in Stroke Prevention: Present and FutureCerebrovascular Diseases, 2006
- Antiplatelets in Stroke Prevention: The MATCH TrialCerebrovascular Diseases, 2005
- Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese CommunityStroke, 2003
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Comparative Safety and Tolerability of Clopidogrel and AspirinDrug Safety, 1999
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Stroke recurrence within 2 years after ischemic infarction.Stroke, 1991
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989